Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Barichello

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
European Urology|January 1, 1992
Relationship between prostatic acid phosphatase and prostate-specific antigen serum levels and prostatic volume in benign prostate hyperplasia. Pitfall on tumor markers assessment in primary prostatic cancer?S Omacini, R Mione, M Barichello, et al.
European Urology|January 1, 1995
Prostate-specific antigen as a unique routine test in monitoring therapy for inoperable prostate cancer: comparison with radionuclide bone scan and prostatic acid phosphataseM Barichello, M Gion, A Bonazza, et al.
Clinical Chemistry|October 1, 1996
Standardization of assay for cytokeratin-related tumor marker CYFRA21.1 in urine samplesR Dittadi, P Barioli, M Gion, et al.
Pathology Research International|March 30, 2018
Accelerated Blood Clearance (ABC) Phenomenon Favors the Accumulation of Tartar Emetic in Pegylated Liposomes in BALB/c Mice LiverTamara C M Lopes, Débora F Silva, Walyson C Costa, et al.
Tumori|November 1, 1996
Preliminary results of clinical evaluation of the free/total prostate-specific antigen ratio in a multicentric studyR Mione, G Aimo, E Bombardieri, et al.
Clinical Chemistry|December 4, 1998
Percent free prostate-specific antigen in assessing the probability of prostate cancer under optimal analytical conditionsM Gion, R Mione, P Barioli, et al.
The International Journal of Biological Markers|November 6, 1998
Prostate cancer probability after total PSA and percent free PSA determinationR Mione, P Barioli, M Barichello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project studyF Boccardo, A Rubagotti, M Barichello, et al.
European Urology|April 15, 2000
Clinical evaluation of percent free prostate-specific antigen using the AxSYM system in the best analytical scenarioM Gion, R Mione, P Barioli, et al.
Journal of Natural Products|December 10, 2019
Nanostructured Systems Improve the Antimicrobial Potential of the Essential Oil from <i>Cymbopogon densiflorus</i> LeavesJanaína B Seibert, Juliana S R Viegas, Tamires C Almeida, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
European Urology|January 1, 1992
Relationship between prostatic acid phosphatase and prostate-specific antigen serum levels and prostatic volume in benign prostate hyperplasia. Pitfall on tumor markers assessment in primary prostatic cancer?S Omacini, R Mione, M Barichello, et al.
European Urology|January 1, 1995
Prostate-specific antigen as a unique routine test in monitoring therapy for inoperable prostate cancer: comparison with radionuclide bone scan and prostatic acid phosphataseM Barichello, M Gion, A Bonazza, et al.
Clinical Chemistry|October 1, 1996
Standardization of assay for cytokeratin-related tumor marker CYFRA21.1 in urine samplesR Dittadi, P Barioli, M Gion, et al.
Pathology Research International|March 30, 2018
Accelerated Blood Clearance (ABC) Phenomenon Favors the Accumulation of Tartar Emetic in Pegylated Liposomes in BALB/c Mice LiverTamara C M Lopes, Débora F Silva, Walyson C Costa, et al.
Tumori|November 1, 1996
Preliminary results of clinical evaluation of the free/total prostate-specific antigen ratio in a multicentric studyR Mione, G Aimo, E Bombardieri, et al.
Clinical Chemistry|December 4, 1998
Percent free prostate-specific antigen in assessing the probability of prostate cancer under optimal analytical conditionsM Gion, R Mione, P Barioli, et al.
The International Journal of Biological Markers|November 6, 1998
Prostate cancer probability after total PSA and percent free PSA determinationR Mione, P Barioli, M Barichello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project studyF Boccardo, A Rubagotti, M Barichello, et al.
European Urology|April 15, 2000
Clinical evaluation of percent free prostate-specific antigen using the AxSYM system in the best analytical scenarioM Gion, R Mione, P Barioli, et al.
Journal of Natural Products|December 10, 2019
Nanostructured Systems Improve the Antimicrobial Potential of the Essential Oil from <i>Cymbopogon densiflorus</i> LeavesJanaína B Seibert, Juliana S R Viegas, Tamires C Almeida, et al.
Pageof 2